Purilogics is currently developing a novel and first-in-market high-capacity, -selectivity, and -throughput affinity membrane for the purification of mRNA.

We’re excited to attend the Antibody Engineering & Therapeutics Conference in San Diego, CA from December 13th to 17th! Hosted by the Antibody Society, which is dedicated to the promotion of antibody research and development, this conference showcases the latest antibody technologies and science to accelerate next generation antibodies towards commercial success.

Purilogics is currently developing a novel and first-in-market high-capacity, -selectivity, and -throughput affinity membrane for the purification of mRNA…

Purilogics, a company recognized for its best-in-class membrane chromatography technology, development, and commercialization, is excited to announce that it has been awarded a significant grant from the National Institutes of Health (NIH) to support the research and development of first-in-market high-capacity, -selectivity, and -throughput affinity membranes for the purification of mRNA. With a grant amount of $1.7M from the Small Business Innovation Research (SBIR) program, Purilogics aims to develop mRNA affinity membranes with enabling accelerated purifications for both small and large mRNAs, as well as create and conduct field research on prototypes through industry collaboration.

Purilogics, a swiftly growing start-up noted for its novel affinity membrane chromatography technology, development, and commercialization, will be presenting their most up-to-date research on their rapid antibody and mRNA purification technologies at the 13th Annual Bioprocessing Summit.

As part of the Small Business Innovative Research (SBIR) program, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Purilogics with a grant to commercialize affinity membrane adsorbers for purification of influenza vaccines.

If you’re in the custom membrane, filter, or protein purification business or research area, chances are you’re always on the lookout for a better membrane holder to pack your material.

We are excited to attend Bioprocessing Summit from August 13 to August 16, 2019 in Boston, MA. Drs. Graham Temples and Jinxiang Zhou will present latest data for our PurexaTM-MQ and PurexaTM-A chromatographic membrane technologies.

Purilogics, as a pioneer in novel high-performance membrane chromatography development, has received a second Small Business Innovation Research (SBIR) grant from National Institute of General Medical Sciences this year. This new award is a SBIR Phase II grant for ~$1.5 M to develop novel, Protein A based affinity chromatographic membranes with high binding capacities.

Purilogics has been awarded an NIH Small Business Innovation Research (SBIR) Phase I grant for $220,772 to commercialize novel lentiviral vector affinity membrane chromatography technology.

Invited by ITOR/Prisma Healthcare, Purilogics team showcased our Purexa™ membrane chromatography technologies at Discover USC 2019 in Columbia, SC, the third annual university-wide showcase of research, scholarship, leadership and creativity.

Purilogics is excited to attend ACS Spring 2019 in Orlando. We would love to talk shop about your purification challenges! Come visit us at our posters 6-8pm April 2nd to see the latest data on our multimodal anion exchange and Protein A membrane chromatography prototypes.